-Substituted arabinofuranosyluracils were suspended in saline containing 3% Tween 80 and injected intracerebroventricularly (i.c.v.).
14) Control mice were injected i.c.v. with 3% Tween 80-saline as a vehicle. Sodium pentobarbital (40 mg/kg) dissolved in saline was administered intraperitoneally (i.p.).
Hypnotic Activity Compounds were administered by i.c.v. injection. Sleeping time was measured as the period between the loss and recovery of the righting reflex.
Pentobarbital-Induced Sleep Prolongation The prolongation effects of N 3 -substituted arabinofuranosyluracil on pentobarbital-induced sleep were assessed by injection of sodium pentobarbital (40 mg/kg, i.p.) 15 min after administration of the test compounds. For the pentobarbital-induced sleep-prolongation effect, the statistical significance of difference between the control and test groups was analyzed by use of a one-way analysis of variance Student's t-test.
Results and Discussion
The CNS depressant effects of 1 and its N 3 -substituted derivatives are summarized in Table 1 . Compound 1, N 3 -methyl (2), ethyl (3), propyl (4), butyl (5), and allyl (6) derivatives did not possess any hypnotic activity in mice at a dose of 2.0 mmol/mouse by i.c.v. injection, whereas N 3 -benzyl (7), o, m-, p-xylyl (8-10), and a-phenylethyl (11) substituted arabinofuranosyluracils possessed hypnotic activity at the same dose. Among them, N 3 -o-xylyl derivative (8) exhibited the strongest hypnotic activity. The values of mean sleeping time induced by 7-11 were 144, 154, 117, 33 and 34 min, respectively. Since 7-11 exhibited hypnotic activity, the hypnotic activities of the derivatives were compared at different doses by i.c.v. injection (Fig. 1) . All compounds showed no hypnotic activity at a dose of 0.5 mmol/mouse by i.c.v. injection. Compounds 7-10 showed 46, 40, 36, and 17 min of sleeping time even at 1.0 mmol/mouse, respectively. The hypnotic activity of 7 was 4-times stronger than that of N 3 -benzyluridine at the dose of 2.0 mmol/mouse (Fig. 1) , indicating an interaction between the N 3 -benzyl substituted group and the 2Ј-hydroxy group on the hypnotic activity. Our previous work 5) demonstrated that N 3 -o-xylyluridine had stronger activity than the benzyl derivative. However, the present study indicates that the o-xylyl derivative of 1 has the same potency as the benzyl derivative in the hypnotic activity test.
The effects of the derivatives on pentobarbital-induced sleep were also evaluated (Table 1) . Although 1 and its N 3 -alkylated derivatives, 2-5 (2.0 mmol/mouse, i.c.v.) did not prolong pentobarbital-induced sleeping time, the N 3 -allyl substituted derivative significantly prolonged the sleeping time, suggesting that the unsaturated bond in the substituent group caused the CNS depressant activity. 6) In addition, benzyl and its related derivatives (benzyl (7), xylyls (8) (9) (10) , and a-phenylethyl (11) derivatives) also significantly prolonged sleeping time at the same dose. Compounds 6-11 possessed 1.5, 3.9, 4.0, 4.6, 2.9, and 2.1-fold of the control sleeping time at 2.0 mmol/mouse. These results did not show the same tendency as found in N 3 -substituted oxopyrimidine nucleosides as previously reported. 5) We previously reported that N 3 -allyl substituted uridine and thymidine exhibited CNS de- pressant activity in mice. 4) The present results also support the conclusion that the N 3 -allyl substituted derivative has CNS depressant activity.
Oxopyrimidine nucleoside 1 alone did not exhibit any hypnotic activity or potentiation of pentobarbital-induced sleep when given by i.c.v. injection. However, chemical modification of the N 3 -position of 1 caused CNS depressant effects in mice. These results indicate that oxopyrimidine nucleosides basically have CNS depressant activity. Therefore, our present results are consistent with the report by Krooth et al. 15) that oxopyrimidine nucleosides decreased mouse locomotor activity by a CNS depressant effect. We previously reported that N 3 -benzyl-or benzyl-related derivatives of uridine, 6-azauridine, thymidine, and 2Ј-deoxyuridine possess hypnotic activity in mice, while the derivatives of 2Ј,3Ј-O-isopropylideneuridine did not. [5] [6] [7] [8] [9] 12) In the present study, N 3 -benzyland xylyl substituted arabinofuranosyluracil derivatives also showed hypnotic activity. These results demonstrate that not only uridine derivatives, but also arabinofuranosyluracil derivatives exhibit hypnotic activity. The structure-activity relationships of arabinofuranosyluracil derivatives were different from those of the oxopyrimidines previously reported. 5) In the case of uridine derivatives, N 3 -o-xylyluridine possessed the most potent hypnotic activity among the uridine derivatives. In the present study, 6-8 showed the same hypnotic activity in mice and had stronger effects as compared with oxopyrimidine nucleosides having the same N 3 -substituents. This result may be due to the structural difference at the 2Ј-hydroxy group on ribose. Recently, we demonstrated the existence of a uridine receptor on the synaptic membrane in mammalian brain. 16) The structural specificity of arabinofuranosyl derivatives for hypnotic activity might also contribute to the conformation of the uridine receptor binding site.
In conclusion, the present study supports our previous findings that N 3 -substituted oxopyrimidine nucleosides such as uridine, 6-azauridine, thymidine, and 2Ј-deoxyuridine possess hypnotic and sedative activities, and that the introduction of benzyl-related groups at the N 3 -position is an important factor for exhibiting the CNS depressant effects of oxopyrimidine nucleoside derivatives, even though the hydroxy group on the 2Ј position of ribose is different from that of uridine. Although arabinofuranosyluracil is not a natural compound, it appeared that arabinofuranosyluracil derivatives basically possess CNS depressant activity, as do uridine derivatives. 
